EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSEEUG00000002801
Gene Symbol: AURKA
1 External references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSEEUG00000015607
Gene Symbol: AURKB
1 External references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSEEUG00000007017
Gene Symbol: BACE1
1 External references
220 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSEEUG00000004097
Gene Symbol: BDKRB2
1 External references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSEEUG00000000607
Gene Symbol: BCHE
3 External references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSEEUG00000005289
Gene Symbol: CALCRL
1 External references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSEEUG00000010612
Gene Symbol: CASR
1 External references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSEEUG00000010019
Gene Symbol: CACNA2D1
1 External references
287 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSEEUG00000011305
Gene Symbol: CACNA2D3
1 External references
213 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 1

Ensembl ID : ENSEEUG00000003589
Gene Symbol: CACNB1
1 External references
208 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 4

Ensembl ID : ENSEEUG00000012533
Gene Symbol: CACNB4
1 External references
251 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1

Ensembl ID : ENSEEUG00000015784
Gene Symbol: CACNG1
1 External references
268 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).